These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 3102504)

  • 41. Plasminogen activator inhibitor type-1 protein, mRNA and gene transcription are increased by phorbol esters in human rhabdomyosarcoma cells.
    Mayer M; Lund LR; Riccio A; Skouv J; Nielsen LS; Stacey SN; Danø K; Andreasen PA
    J Biol Chem; 1988 Oct; 263(30):15688-93. PubMed ID: 3262618
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cells of the human myelomonocytic line RC-2A synthesize tissue factor-like procoagulant and urokinase-type plasminogen activator.
    Karhumäki E; Saravo L; Helin H
    J Leukoc Biol; 1987 Jul; 42(1):36-42. PubMed ID: 3298513
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor necrosis factor-alpha regulates mRNA for urokinase-type plasminogen activator and type-1 plasminogen activator inhibitor in human neoplastic cell lines.
    Georg B; Helseth E; Lund LR; Skandsen T; Riccio A; Danø K; Unsgaard G; Andreasen PA
    Mol Cell Endocrinol; 1989 Jan; 61(1):87-96. PubMed ID: 2501120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells.
    Pöllänen J; Saksela O; Salonen EM; Andreasen P; Nielsen L; Danø K; Vaheri A
    J Cell Biol; 1987 Apr; 104(4):1085-96. PubMed ID: 3104349
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of urokinase plasminogen activator receptor in resting and activated bovine neutrophils.
    Politis I; Zavizjon B; Cheli F; Baldi A
    J Dairy Res; 2002 May; 69(2):195-204. PubMed ID: 12222798
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
    Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
    J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cell- and gene-specific interactions between signal transduction pathways revealed by okadaic acid. Studies on the plasminogen activating system.
    Medcalf RL
    J Biol Chem; 1992 Jun; 267(17):12220-6. PubMed ID: 1318313
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro.
    Pepper MS; Belin D; Montesano R; Orci L; Vassalli JD
    J Cell Biol; 1990 Aug; 111(2):743-55. PubMed ID: 1696269
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme.
    Andreasen PA; Nielsen LS; Kristensen P; Grøndahl-Hansen J; Skriver L; Danø K
    J Biol Chem; 1986 Jun; 261(17):7644-51. PubMed ID: 3086313
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of plasminogen activator inhibitor 1 biosynthesis by hyperthermia.
    Bergonzelli GE; Kruithof EK
    J Cell Physiol; 1991 Aug; 148(2):306-13. PubMed ID: 1652590
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.
    Lawrence D; Strandberg L; Grundström T; Ny T
    Eur J Biochem; 1989 Dec; 186(3):523-33. PubMed ID: 2514093
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differences between the F10, BL6 and F1 sublines of the B16 melanoma in the enhancement of plasminogen activator and plasminogen activator inhibitor secretion by phorbol myristate acetate.
    Hart DA; Smith R
    Cancer Lett; 1987 Apr; 35(1):27-38. PubMed ID: 3105864
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states.
    Kruithof EK; Gudinchet A; Bachmann F
    Thromb Haemost; 1988 Feb; 59(1):7-12. PubMed ID: 3129809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta.
    Ye RD; Wun TC; Sadler JE
    J Biol Chem; 1987 Mar; 262(8):3718-25. PubMed ID: 3029122
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis of urokinase-type plasminogen activator and of type-1 plasminogen activator inhibitor in neuronal cultures of human fetal brain: stimulation by phorbol ester.
    Presta M; Ennas MG; Torelli S; Ragnotti G; Gremo F
    J Neurochem; 1990 Nov; 55(5):1647-54. PubMed ID: 2213017
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phorbol ester and mitogens stimulate human fibroblast secretions of plasmin-activatable plasminogen activator and protease nexin, an antiactivator/antiplasmin.
    Eaton DL; Baker JB
    J Cell Biol; 1983 Aug; 97(2):323-8. PubMed ID: 6224800
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional characteristics of receptor-bound urokinase on human monocytes: catalytic efficiency and susceptibility to inactivation by plasminogen activator inhibitors.
    Kirchheimer JC; Remold HG
    Blood; 1989 Sep; 74(4):1396-402. PubMed ID: 2548640
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
    de Bart AC; Quax PH; Löwik CW; Verheijen JH
    J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of both type 1 and type 2 plasminogen activator inhibitors in human cells.
    Schleef RR; Wagner NV; Loskutoff DJ
    J Cell Physiol; 1988 Feb; 134(2):269-74. PubMed ID: 3257967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.